CSTL · Castle Biosciences Inc
$24.70
-0.79 (-3.08%)
At close · Jul 24
Market Cap
$748.69M
Shares
30.33M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-06-30 | — | |
| 8-K | 2026-05-29 | 2026-05-28 | |
| 10-Q | 2026-05-06 | 2026-03-31 | |
| 8-K | 2026-05-06 | — | |
| DEF 14A | 2026-04-08 | 2026-05-28 | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K | 2026-02-26 | — | |
| 8-K | 2026-01-13 | 2026-01-11 | |
| 8-K | 2025-11-03 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-08-08 | 2025-08-05 | |
| 8-K | 2025-08-04 | — | |
| 10-Q | 2025-08-04 | 2025-06-30 | |
| 8-K | 2025-05-23 | 2025-05-22 | |
| 10-Q | 2025-05-05 | 2025-03-31 | |
| 8-K | 2025-05-05 | — | |
| DEF 14A | 2025-04-09 | 2025-05-22 | |
| 10-K | 2025-02-27 | 2024-12-31 | |
| 8-K | 2025-02-27 | — | |
| 8-K | 2025-01-13 | 2025-01-12 | |
| 8-K | 2024-11-04 | — | |
| 10-Q | 2024-11-04 | 2024-09-30 | |
| 10-Q | 2024-08-05 | 2024-06-30 | |
| 8-K | 2024-08-05 | — | |
| 8-K | 2024-05-24 | 2024-05-23 | |
| 8-K | 2024-05-02 | — | |
| 10-Q | 2024-05-02 | 2024-03-31 | |
| DEF 14A | 2024-04-10 | — | |
| 8-K | 2024-03-27 | 2024-03-26 | |
| 8-K | 2024-02-28 | — | |
| 10-K | 2024-02-28 | 2023-12-31 | |
| 8-K | 2024-01-08 | 2024-01-07 | |
| 8-K | 2023-11-09 | 2023-11-03 | |
| 10-Q | 2023-11-02 | 2023-09-30 | |
| 8-K | 2023-11-02 | — | |
| 10-Q | 2023-08-02 | 2023-06-30 | |
| 8-K | 2023-08-02 | — | |
| 8-K | 2023-06-05 | — | |
| 8-K | 2023-06-01 | 2023-05-25 | |
| 10-Q | 2023-05-03 | 2023-03-31 | |
| 8-K | 2023-05-03 | — | |
| DEF 14A | 2023-04-12 | 0001-01-01 | |
| 8-K | 2023-02-28 | — | |
| 10-K | 2023-02-28 | 2022-12-31 | |
| 8-K | 2023-01-20 | 2023-01-13 | |
| 8-K | 2023-01-09 | 2023-01-08 | |
| 8-K | 2022-12-28 | 2022-12-22 | |
| 8-K | 2022-12-15 | 2022-12-09 | |
| 10-Q | 2022-11-02 | 2022-09-30 | |
| 8-K | 2022-11-02 | — |
Showing 1–50 of 104 filings
Key facts
CIK
1447362
CUSIP
14843C105
13F (30d)
23 filings
23 filers
Visit website
Investor relations